Details for New Drug Application (NDA): 085983
✉ Email this page to a colleague
NDA 085983 describes THEOBID, which is a drug marketed by Whitby and is included in two NDAs. Additional details are available on the THEOBID profile page.
The generic ingredient in THEOBID is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in THEOBID is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 085983
| Tradename: | THEOBID |
| Applicant: | Whitby |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085983
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 260MG | ||||
| Approval Date: | Mar 20, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
